Navigation Links
USC research IDs potential treatment for deadly, HIV-related blood cancer
Date:6/25/2013

LOS ANGELES Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.

The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma (PEL), a type of cancer for which those drugs were not expected to be effective.

"It's a reversal of the paradigm," said Preet Chaudhary, MD, PhD, chief of the Nohl Division of Hematology and Blood Diseases at the Keck School of Medicine of USC and principal investigator of the study. "Our results suggest that this new class of drug may be an effective treatment for a wider range of cancers than previously thought."

PEL is caused by infection with Kaposi's sarcoma-associated herpes virus, the most common cause of cancer among patients with AIDS. The prognosis for PEL is poor, with a median survival of three to six months. Thus, there is a critical need for new therapies for the disease.

Chaudhary and his colleagues show that inhibitors targeting the BRD4 protein blocked growth of PEL cells in a test tube and in a mouse model. The results were surprising because BET inhibitors were thought to be only effective against cancers linked to an overexpression of the Myc gene.

"We actually found that cancers that overexpress Myc are not as responsive to BRD4 inhibitors. PEL is more responsive," Chaudhary said.

Cancers like multiple myeloma and Burkitt's lymphoma overexpress the Myc gene and have been shown to respond to BRD4 inhibitors. In PEL, the Myc gene is moderately expressed and there is no chromosomal translocation as is seen in multiple myeloma or Burkitt's.

More research is needed to create compounds ready for testing in people. Once those drugs are ready for clinical trial, data from this study suggest that they may treat a wide range of cancers. Chaudhary anticipates testing the
'/>"/>

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MS researchers determine that brain reserve independently protects against cognitive decline in MS
2. New screening approach identifies small proteins unique to melanoma cells, Moffitt researcher says
3. American Brain Tumor Association’s 2013 Patient & Family Conference Highlights Emerging Research
4. Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
5. Ethanol Leads Renewable Chemicals Market; Polymers Sector 14.3% CAGR Growth Forecasted by 2018 Says New Research Report at ReportsnReports.com
6. Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
7. Citrus, Banana and Other Fruit Growing in Australia Industry Market Research Report Now Updated by IBISWorld
8. Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers
9. Going to synagogue is good for health and happiness, Baylor researcher finds
10. Consider a text for teen suicide prevention and intervention, research suggests
11. America will never be gay and lesbian friendly, says researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... 28, 2014 Parker Waichman LLP, a personal ... ensure that the heroes of 9/11 are never forgotten, comments ... an important deadline. According to a VCF message ... covered cancer on or before October 12, 2012 must file ... responders and others who were allegedly injured by the toxic ...
(Date:7/28/2014)... July 28, 2014 Bariatric Eating, a ... announced that it will be introducing three additional flavors ... this summer. The additional flavors include: , Inspire Summer ... protein , Inspire Pomegranate Razz Berry -­ Pomegranate, razz ... soft-serve vanilla cone , Bariatric Eating's Inspire protein ...
(Date:7/28/2014)... 28, 2014 Mirena IUD lawsuits ( ... caused some users to suffer serious injuries after it ... continue to mount in U.S. courts, Bernstein Liebhard LLP ... last month in New Jersey, at least 924 Mirena ... litigation underway in Bergen County Superior Court. Some 148 ...
(Date:7/28/2014)... July 28, 2014 St. Jude Children’s ... of the Secretary of Defense Employer Support Freedom Award from ... the Department of Defense. The award is the highest honor ... support of employees who serve in the National Guard and ... the military for their contributions to the St. Jude mission ...
Breaking Medicine News(10 mins):Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 4Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 2Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 3
... less likely to separate reality from fiction , , MONDAY, ... and television shows as children become sexually active at a ... finds. , It included 754 participants who were monitored during ... 12 to 18. The earlier in their life they were ...
... Clinical Data Presented at Society of American Gastroenterological ... May 4 USGI Medical, Inc. (USGI), announced ... in three podium sessions at the 2009 Society ... Session & Postgraduate Course, held in Phoenix, Arizona.Dr. ...
... WASHINGTON, May 4 The Consumer Healthcare Products Association ... more parents than ever are addressing over-the-counter (OTC) cough ... Tracking Study (PATS) indicates that 65 percent of parents ... using OTC cough and cold medicine to get high, ...
... of Online, Educational Resources Aims to Empower Children With ... , NEW YORK, May 4 ... across the country, BrainPOP -- ... 3 and up -- has launched a new, free ...
... Into Electronic Medical Records; Patient Privacy is ProtectedNEW YORK, ... Medical Center used to take months, required a ... elaborate research review process. Now, many of these ... matter of minutes using a breakthrough software called Clinical ...
... Billion FY 2010 Proposed Medicare Cut Weakens Key Health ... WorkforceJOPLIN, Mo., May 4 The Coalition to Protect ... defeat a Medicare regulation put forward for implementation Friday ... The proposed Medicare rule, a Coalition spokeswoman said, would ...
Cached Medicine News:Health News:Viewing Adult-Themed TV Tied to Earlier Sex for Teens 2Health News:Studies Report Use of USGI Medical's Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures 2Health News:Studies Report Use of USGI Medical's Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures 3Health News:Partnership for a Drug-Free America / MetLife Foundation Survey Shows More Parents Are Talking With Their Teens About Cough Medicine Abuse 2Health News:Free New Content From BrainPOP Helps Explain Swine Flu to Kids 2Health News:Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center 2Health News:Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center 3Health News:Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center 4Health News:Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center 5Health News:Nation's Front Line Caregivers Mobilizing to Help Defeat Obama Implementation of Damaging Medicare Regulation 2
(Date:7/28/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China , today announced that on ... special cash dividend of US$0.30 per ordinary share (or ... outstanding ordinary shares. The total expense for the special ...
(Date:7/28/2014)... , July 28, 2014  ImaginAb, Inc. today ... Crystal , MD as Vice President of Business Development. ... Development Product Acquisition & Licensing team at G.E. Life ... strategy and partnerships in the precision medicine space will ... biotechnology and pharmaceutical companies across the spectrum to extend ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... , WALTHAM, Mass., Nov. 17 Decision Resources, one of ... healthcare issues, finds that sales of agents to treat acute ... increasing from $360 million in 2008 to $450 million in ... United Kingdom and Japan. , The new Pharmacor report entitled ...
... , REYKJAVIK, Iceland, Nov. 17 ... it has filed a voluntary petition for relief under Chapter ... States Bankruptcy Court for the District of Delaware to facilitate ... continuing to operate its business and manage its properties as ...
Cached Medicine Technology:Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018 2deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 2deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 3deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 4
Hydrophobic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack....
... Hydroview™ hydrophilic acrylic IOL is the ... truly designed with the patient and surgeon ... a hydrogel optic polymerically crosslinked with PMMA ... use, and excellent visual performance and biocompatibility. ...
Raysoft Foldable Intraocular Lens....
Medicine Products: